Phentolamine Mesylate | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Phentolamine Mesylate
US Patents

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

Contact Supplier

xyz-pharma-m-2025-03-24

Contact Supplier

LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Contact Supplier

Gentec Pharmaceutical Group is focused on manufacturing & developing APIs/HPAPIs, Advanced Intermediates & Fine Chemicals.

Contact Supplier

xyz-pharma-m-2025-03-17

Contact Supplier

Phentolamine Mesylate

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

10 API Suppliers, 6 USDMF, 1 CEP/COS, 1 EU WC, 15 NDC API, 7 Listed Suppliers, $ API Reference Price

10 API Suppliers
6 USDMF
1 CEP/COS
1 EU WC
15 NDC API
7 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

29 Drugs in Development

29 Drugs in Development

FINISHED DOSAGE FORMULATIONS

12 FDF Dossiers, 5 FDA Orange Book, 2 Canada, 5 Listed Dossiers

12 FDF Dossiers
5 FDA Orange Book
2 Canada
5 Listed Dossiers

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 13 SPI Pharma, 1 Faran Shimi Pharmaceutical, 1 Gangwal Healthcare, 1 Pfanstiehl, 1 BASF, 2 Gangwal Chemicals, 1 Ingredion Pharma Solutions, 2 Kerry, 2 Microlex e.U, 1 Pluviaendo, 3 Roquette, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Sigachi Industries

1 Rochem International Inc
13 SPI Pharma
1 Faran Shimi Pharmaceutical
1 Gangwal Healthcare
1 Pfanstiehl
1 BASF
2 Gangwal Chemicals
1 Ingredion Pharma Solutions
2 Kerry
2 Microlex e.U
1 Pluviaendo
3 Roquette
1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
1 Shijiazhuang Huaxu Pharmaceutical
1 Sigachi Industries

EXCIPIENTS BY APPLICATIONS

17 Fillers, Diluents & Binders, 11 Chewable & Orodispersible Aids, 10 Taste Masking, 10 Direct Compression, 7 Disintegrants & Superdisintegrants, 5 Co-Processed Excipients, 4 Parenteral, 3 Granulation, 1 Solubilizers, 1 Thickeners and Stabilizers

17 Fillers, Diluents & Binders
11 Chewable & Orodispersible Aids
10 Taste Masking
10 Direct Compression
7 Disintegrants & Superdisintegrants
5 Co-Processed Excipients
4 Parenteral
3 Granulation
1 Solubilizers
1 Thickeners and Stabilizers

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 26 News #PharmaBuzz

1 Data Compilation #PharmaFlow
26 News #PharmaBuzz

MARKET PLACE

16 APIs, 1 FDF Dossiers

16 APIs
1 FDF Dossiers

PATENTS & EXCLUSIVITIES

8 US Patents, 1 US Exclusivities, 2 Health Canada Patents

8 US Patents
1 US Exclusivities
2 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 1 USP, 3 Others

3 EDQM
1 USP
3 Others

$ API Ref.Price (USD/KG) : 54,143 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

8 All

01 8FAMYGEN LIFE SCI

filter Patent Number Reset all filters

8 All

01 19795560

02 110278918

03 110772829

04 111090261

05 111400077

06 111844858

07 112201615

08 112201616

filter API Patent Reset all filters

8 All

01 8Blank

filter FDF Patent Reset all filters

8 All

01 5Y

02 3Blank

filter Expiration Date Reset all filters

8 All

01 52034-01-31

02 22039-10-25

03 12039-12-25

Product Main Page

01

FAMYGEN LIFE SCI

PHENTOLAMINE MESYLATE

Immuno-Oncology 360

Not Confirmed

FAMYGEN LIFE SCI

Country

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2039-10-25

PHENTOLAMINE MESYLATE

US Patent Number : 12201616

Drug Substance Claim :

Drug Product Claim :

Application Number : 217064

Patent Use Code : U-3804

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-10-25

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

02

FAMYGEN LIFE SCI

PHENTOLAMINE MESYLATE

Immuno-Oncology 360

Not Confirmed

FAMYGEN LIFE SCI

Country

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2039-12-25

PHENTOLAMINE MESYLATE

US Patent Number : 12201615

Drug Substance Claim :

Drug Product Claim :

Application Number : 217064

Patent Use Code : U-3804

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-12-25

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

03

FAMYGEN LIFE SCI

PHENTOLAMINE MESYLATE

Immuno-Oncology 360

Not Confirmed

FAMYGEN LIFE SCI

Country

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2039-10-25

PHENTOLAMINE MESYLATE

US Patent Number : 11400077

Drug Substance Claim :

Drug Product Claim :

Application Number : 217064

Patent Use Code : U-3804

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-10-25

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

04

FAMYGEN LIFE SCI

PHENTOLAMINE MESYLATE

Immuno-Oncology 360

Not Confirmed

FAMYGEN LIFE SCI

Country

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2034-01-31

PHENTOLAMINE MESYLATE

US Patent Number : 11844858

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 217064

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-01-31

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

05

FAMYGEN LIFE SCI

PHENTOLAMINE MESYLATE

Immuno-Oncology 360

Not Confirmed

FAMYGEN LIFE SCI

Country

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2034-01-31

PHENTOLAMINE MESYLATE

US Patent Number : 9795560

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 217064

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-01-31

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

06

FAMYGEN LIFE SCI

PHENTOLAMINE MESYLATE

Immuno-Oncology 360

Not Confirmed

FAMYGEN LIFE SCI

Country

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2034-01-31

PHENTOLAMINE MESYLATE

US Patent Number : 11090261

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 217064

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-01-31

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

07

FAMYGEN LIFE SCI

PHENTOLAMINE MESYLATE

Immuno-Oncology 360

Not Confirmed

FAMYGEN LIFE SCI

Country

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2034-01-31

PHENTOLAMINE MESYLATE

US Patent Number : 10278918

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 217064

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-01-31

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

08

FAMYGEN LIFE SCI

PHENTOLAMINE MESYLATE

Immuno-Oncology 360

Not Confirmed

FAMYGEN LIFE SCI

Country

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2034-01-31

PHENTOLAMINE MESYLATE

US Patent Number : 10772829

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 217064

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-01-31

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!